Tunc Murat, Onder Halil Ibrahim, Kaya Murat
Department of Ophthalmology, Abant Izzet Baysal University Düzce Medical School, Düzce, Turkey.
Ophthalmology. 2005 Jun;112(6):1086-91. doi: 10.1016/j.ophtha.2004.12.039.
To investigate the efficacy of posterior sub-Tenon's capsule triamcinolone injection (PSTI) combined with focal laser (FL) photocoagulation in treatment of diffuse clinically significant diabetic macular edema (CSME).
Prospective randomized clinical study.
Sixty patients with diffuse CSME.
We randomized the patients who had CSME into 2 treatment groups. A total of 30 eyes received macular focal and grid laser photocoagulation (MP), and the second group of 30 eyes received FL photocoagulation combined with PSTI (FL + PSTI). Clinical and visual evaluations were performed at baseline and 12 and 18 weeks after treatment, and the results were compared by statistical methods.
Early Treatment Diabetic Retinopathy Study (ETDRS) visual acuity (VA) scores and clinical changes in macular edema.
Before treatment, mean ETDRS VA scores were 45.9+/-12.7 (mean +/- standard deviation [SD]; range, 24-66) in MP (focal + grid laser) and 44.5+/-12.6 (range, 22-66) in the FL + PSTI group. Early Treatment Diabetic Retinopathy Study scores at 18 weeks were 46.4+/-14.2 (range, 20-70) after MP and 52.5+/-17.5 (range, 22-82) after FL + PSTI. Early Treatment Diabetic Retinopathy Study scores significantly improved in eyes that received FL + PSTI (P = 0.0001, paired t test). The FL + PSTI group had an increase of 12.4+/-7.1 (range, 5-26) ETDRS letters, and the MP group had an increase of 7.8+/-3.1 (range, 5-15) letters (P = 0.04, unpaired t test). Twelve of 30 (40%) cases in the MP group and 24 of 30 (80%) cases in the FL + PSTI group showed clinical improvement in macular edema according to the stereoscopic evaluation of fundus and fluorescein angiography (P = 0.003).
Posterior sub-Tenon's capsule application of triamcinolone may improve early visual outcome in diffuse diabetic macular edema when combined with FL photocoagulation.
探讨后Tenon囊下注射曲安奈德(PSTI)联合局部激光(FL)光凝治疗弥漫性临床显著性糖尿病黄斑水肿(CSME)的疗效。
前瞻性随机临床研究。
60例弥漫性CSME患者。
将患有CSME的患者随机分为2个治疗组。第一组30只眼接受黄斑局部格栅样激光光凝(MP),第二组30只眼接受FL光凝联合PSTI(FL + PSTI)。在基线、治疗后12周和18周进行临床和视力评估,并采用统计学方法比较结果。
早期糖尿病视网膜病变研究(ETDRS)视力(VA)评分及黄斑水肿的临床变化。
治疗前,MP组(局部+格栅样激光)的平均ETDRS VA评分为45.9±12.7(平均值±标准差[SD];范围,24 - 66),FL + PSTI组为44.5±12.6(范围,22 - 66)。MP组治疗18周后的ETDRS评分为46.4±14.2(范围,20 - 70),FL + PSTI组为52.5±17.5(范围,22 - 82)。接受FL + PSTI治疗的眼的ETDRS评分显著改善(P = 0.0001,配对t检验)。FL + PSTI组ETDRS字母增加了12.4±7.1(范围,5 - 26),MP组增加了7.8±3.1(范围,5 - 15)(P = 0.04,非配对t检验)。根据眼底立体评估和荧光素血管造影,MP组30例中有12例(40%)、FL + PSTI组30例中有24例(80%)黄斑水肿有临床改善(P = 0.003)。
后Tenon囊下应用曲安奈德联合FL光凝可改善弥漫性糖尿病黄斑水肿的早期视力预后。